Additionally, a recent study by Sundell et al. identified that mutations in CYP1A2 are associated with a 50% reduction in relative bioavailability in adult patients coinfected with HIV/TB, and this may result in underexposure to ethambutol [11]. This evidence concerns the gene CYP1A2 and tuberculosis.